Bayesian adaptive methods for clinical trials
From MaRDI portal
Publication:3576260
Bayesian approachdrug developmentfrequentist approachmedical device developmentPhase I trialPhase II trialPhase III trial
Bayesian inference (62F15) Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) General biostatistics (92B15) Bayesian problems; characterization of Bayes procedures (62C10) Introductory exposition (textbooks, tutorial papers, etc.) pertaining to statistics (62-01) Introductory exposition (textbooks, tutorial papers, etc.) pertaining to biology (92-01)
Recommendations
Cited in
(38)- Flexible link continual reassessment methods for trivariate binary outcome phase I/II trials
- Bayesian adaptive trial design for a newly validated surrogate endpoint
- scientific article; zbMATH DE number 5898591 (Why is no real title available?)
- Combining Bayesian experimental designs and frequentist data analyses: motivations and examples
- scientific article; zbMATH DE number 1984442 (Why is no real title available?)
- An optimal allocation for response-adaptive designs
- Bayesian designs and the control of frequentist characteristics: a practical solution
- Bootstrapped Bayesian analyses of two adaptive clinical trials
- Bayesian Response-Adaptive Designs for Basket Trials
- Power-weighted densities for time series data
- A two-stage design for comparative clinical trials: the heteroscedastic solution
- Adaptive design theory and implementation using SAS and R.
- Bayesian statistics and the efficiency and ethics of clinical trials
- scientific article; zbMATH DE number 7370531 (Why is no real title available?)
- Active sequential hypothesis testing
- An Approximation Approach for Response-Adaptive Clinical Trial Design
- Bayesian Nonparametric Common Atoms Regression for Generating Synthetic Controls in Clinical Trials
- Two-stage randomized clinical trials with a right-censored endpoint: comparison of frequentist and Bayesian adaptive designs
- Bayesian hierarchical EMAX model for dose-response in early phase efficacy clinical trials
- Approximating the operating characteristics of Bayesian uncertainty directed trial designs
- Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials
- Web-based statistical tools for the analysis and design of clinical trials that incorporate historical controls
- Generalized Likelihood Ratio Statistics and Uncertainty Adjustments in Efficient Adaptive Design of Clinical Trials
- Frequentist test in Bayesian two-stage designs applied in experimental trials
- The Bayesian simulation study (BASIS) framework for simulation studies in statistical and methodological research
- Bayesian sequential analysis of clinical trials feedback
- Rejoinder: Approximate models and robust decisions
- Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials
- Bayesian adaptive designs for clinical trials
- Bayesian bandits in clinical trials
- Handbook of methods for designing, monitoring, and analyzing dose-finding trials
- Bayesian adaptive randomization with compound utility functions
- A Bayesian adaptive phase I/II clinical trial design with late‐onset competing risk outcomes
- Robust meta‐analytic‐predictive priors in clinical trials with historical control information
- Bayesian methods in pharmaceutical research
- Elastic priors to dynamically borrow information from historical data in clinical trials
- Estimating design operating characteristics in Bayesian adaptive clinical trials
- Bayesian doubly adaptive randomization in clinical trials
This page was built for publication: Bayesian adaptive methods for clinical trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3576260)
